The treatment works by taking a sample of the patient's tumour, identifying its unique mutational signature, and then using ...

The US Food and Drug Administration (FDA) has approved the first flu vaccine built on messenger RNA (mRNA) technology, months after the agency refused to even consider the application.

Moderna’s mFLUSIVA is the first mRNA vaccine approved for seasonal flu. Its route to approval was unusual, with the FDA ...